Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,173
Closed -$204K 436
2022
Q1
$204K Buy
+4,173
New +$211K 0.03% 380
2021
Q2
Sell
-824
Closed -$38K 1216
2021
Q1
$38K Sell
824
-3,107
-79% -$130K 0.01% 730
2020
Q4
$127K Sell
3,931
-521
-12% -$15.1K 0.03% 399
2020
Q3
$94K Buy
4,452
+4
+0.1% +$83 0.02% 424
2020
Q2
$91K Sell
4,448
-266
-6% -$5.15K 0.03% 382
2020
Q1
$83K Sell
4,714
-98
-2% -$3.02K 0.04% 366
2019
Q4
$189K Buy
+4,812
New +$177K 0.07% 250

Other funds holding SNV

Eudaimonia Partners's SNV Position: Q2 2022 in Review

Eudaimonia Partners sold out of Synovus (SNV) in Q2 2022, closing a stake of 4,173 shares — an estimated $204K sold.

Eudaimonia Partners first reported a position in SNV in Q4 2019 and held it in 7 quarters. The position peaked at $204K in Q1 2022. 417 funds tracked by Wall St. Rank hold SNV as of Q2 2022.

  • Eudaimonia Partners reported no remaining Synovus position as of Q2 2022 after selling out during the quarter.
  • Eudaimonia Partners sold 4,173 Synovus shares in Q2 2022, an estimated $204K.
  • Eudaimonia Partners first reported a position in Synovus in Q4 2019 and held it in 7 quarters.
  • Eudaimonia Partners's Synovus position peaked at $204K in Q1 2022.
  • 417 funds tracked by Wall St. Rank held Synovus as of Q2 2022.

Based on Eudaimonia Partners's 13F filing for Q2 2022, filed 9 Aug 2022.